Miguel Angel Sanchez-Garrido

Has grant

Postdoctoral/Professor

Universidad de Córdoba

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Miguel Angel Sanchez-Garrido is a Postdoctoral Professor at the Universidad de Córdoba, Spain. His research areas focus on metabolic disorders, reproductive health, and therapeutic strategies for obesity and diabetes. Recent publications highlight his work on the effects of GLP-1-based therapies in polycystic ovary syndrome and the mechanisms of early nutritional programming on health outcomes.

Recent Grants

Grant: Close

CIBERobn

Open Date: 2007-01-01

Close Date:

Articles (7)

Year:

2024

Year:

2022

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Kerstin Stemmer

Professor for Molecular Cell Biology

University of Augsburg

GERMANY

View details

Carmelo Quarta

University of Bordeaux

FRANCE

View details

David Garcia Galiano

Assistant Professor

Universidad de Córdoba

SPAIN

View details

Bart Staels

Head of Department / PUPH

Université de Lille

FRANCE

View details

Manuel Tena-Sempere

University of Turku

FINLAND

View details

Cristina García-Cáceres

W2 Professor

LMU Klinikum

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Miguel Angel Sanchez-Garrido

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (7)

Superior metabolic improvement of polycystic ovary syndrome traits after GLP1-based multi-agonist therapy

GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice.

Early programming of reproductive health and fertility: novel neuroendocrine mechanisms and implications in reproductive medicine.

Early overnutrition sensitizes the growth hormone axis to the impact of diet-induced obesity via sex-divergent mechanisms.

Targeted pharmacological therapy restores β-cell function for diabetes remission.

Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.

Tetrahydrocannabinolic acid A (THCA-A) reduces adiposity and prevents metabolic disease caused by diet-induced obesity

Collaborators (6)

Kerstin Stemmer

Carmelo Quarta

David Garcia Galiano

Bart Staels

Manuel Tena-Sempere

Cristina García-Cáceres

Make your next move.